| Apr 2, 2025 |
Apr 4, 2025 |
Voyager Therapeutics, Inc.
|
CEO |
Sell |
46.3
|
-10,885
|
-2.46%
|
✗
|
$37.3K |
| Feb 20, 2025 |
Feb 24, 2025 |
Voyager Therapeutics, Inc.
|
CEO |
Sell |
91.3
|
+133,298
|
43.21%
|
✗
|
$49.6K |
| Feb 11, 2025 |
Feb 12, 2025 |
Voyager Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-16,644
|
-5.12%
|
✗
|
$74.1K |
| Apr 2, 2024 |
Apr 3, 2024 |
Voyager Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-12,115
|
-3.62%
|
✗
|
$119.5K |
| Feb 21, 2024 |
Feb 22, 2024 |
Voyager Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-13,033
|
-3.75%
|
✗
|
$97.2K |
| Apr 3, 2023 |
Apr 5, 2023 |
Voyager Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-7,437
|
-3.35%
|
✗
|
$58.2K |
| Jun 7, 2021 |
Jun 9, 2021 |
BIOGEN INC.
|
Head of Research & Development |
Sell |
5.0
|
-7,672
|
-43.00%
|
✓
|
$3.4M |
| Feb 12, 2021 |
Feb 17, 2021 |
BIOGEN INC.
|
EVP, Research & Development |
Sell |
40.0
|
-3,510
|
-4.73%
|
✗
|
$975.9K |
| Nov 4, 2020 |
Nov 6, 2020 |
BIOGEN INC.
|
EVP, Research & Development |
Sell |
22.5
|
-1,500
|
-10.30%
|
✓
|
$525K |
| Feb 15, 2020 |
Feb 19, 2020 |
BIOGEN INC.
|
EVP, Research & Development |
Sell |
22.5
|
-538
|
-3.58%
|
✗
|
$179.2K |
| Feb 12, 2020 |
Feb 14, 2020 |
BIOGEN INC.
|
EVP, Research & Development |
Sell |
20.0
|
-1,901
|
-4.67%
|
✗
|
$630.7K |
| Feb 22, 2019 |
Feb 26, 2019 |
BIOGEN INC.
|
EVP, Chief Medical Officer |
Sell |
22.5
|
-739
|
-6.63%
|
✗
|
$240.4K |
| Feb 15, 2019 |
Feb 20, 2019 |
BIOGEN INC.
|
EVP, Chief Medical Officer |
Sell |
22.5
|
-586
|
-5.82%
|
✗
|
$195.1K |
| Feb 12, 2019 |
Feb 14, 2019 |
BIOGEN INC.
|
EVP, Chief Medical Officer |
Sell |
20.0
|
-2,518
|
-7.56%
|
✗
|
$804.3K |
| Feb 27, 2018 |
Feb 28, 2018 |
BIOGEN INC.
|
EVP, Chief Medical Officer |
Sell |
37.5
|
-259
|
-3.80%
|
✓
|
$75.3K |
| Feb 23, 2018 |
Feb 27, 2018 |
BIOGEN INC.
|
EVP, Chief Medical Officer |
Sell |
26.3
|
-1,116
|
-7.71%
|
✓
|
$327.3K |
| Feb 22, 2018 |
Feb 26, 2018 |
BIOGEN INC.
|
EVP, Chief Medical Officer |
Sell |
22.5
|
-727
|
-8.88%
|
✗
|
$207.1K |
| Feb 20, 2018 |
Feb 21, 2018 |
BIOGEN INC.
|
EVP, Chief Medical Officer |
Sell |
25.0
|
-743
|
-10.18%
|
✓
|
$217K |
| Feb 15, 2018 |
Feb 20, 2018 |
BIOGEN INC.
|
EVP, Chief Medical Officer |
Sell |
17.5
|
-1,294
|
-15.06%
|
✓
|
$386.7K |
| Feb 15, 2018 |
Feb 20, 2018 |
BIOGEN INC.
|
EVP, Chief Medical Officer |
Sell |
22.5
|
-596
|
-6.49%
|
✗
|
$178.4K |
| Feb 12, 2018 |
Feb 14, 2018 |
BIOGEN INC.
|
EVP, Chief Medical Officer |
Sell |
20.0
|
-1,316
|
-8.37%
|
✗
|
$416.7K |
| Apr 3, 2017 |
Apr 4, 2017 |
BIOGEN INC.
|
EVP CMO Neuro & Neurodegenerat |
Sell |
12.5
|
-1,981
|
-21.91%
|
✓
|
$543K |
| Mar 1, 2017 |
Mar 3, 2017 |
BIOGEN INC.
|
EVP CMO Neuro & Neurodegenerat |
Sell |
26.3
|
-973
|
-9.72%
|
✓
|
$282.2K |
| Feb 28, 2017 |
Mar 2, 2017 |
BIOGEN INC.
|
EVP CMO Neuro & Neurodegenerat |
Sell |
20.0
|
-2,981
|
-5.11%
|
✗
|
$829.2K |
| Feb 25, 2016 |
Feb 26, 2016 |
BIOGEN INC.
|
EVP CMO Neuro & Neurodegenerat |
Sell |
45.0
|
-183
|
-2.24%
|
✓
|
$47.9K |
| Feb 23, 2016 |
Feb 25, 2016 |
BIOGEN INC.
|
EVP CMO Neuro & Neurodegenerat |
Sell |
26.3
|
-164
|
-1.97%
|
✗
|
$42.5K |
| Feb 17, 2016 |
Feb 19, 2016 |
BIOGEN INC.
|
EVP CMO Neuro & Neurodegenerat |
Sell |
28.8
|
-722
|
-8.29%
|
✓
|
$184.9K |
| Feb 12, 2016 |
Feb 17, 2016 |
BIOGEN INC.
|
EVP CMO Neuro & Neurodegenerat |
Sell |
20.0
|
-1,827
|
-5.38%
|
✗
|
$451.7K |
| Feb 8, 2016 |
Feb 10, 2016 |
BIOGEN INC.
|
EVP CMO Neuro & Neurodegenerat |
Sell |
22.5
|
-1,278
|
-14.17%
|
✓
|
$316.9K |
| Dec 3, 2015 |
Dec 7, 2015 |
BIOGEN INC.
|
EVP CMO Neuro & Neurodegenerat |
Sell |
28.8
|
-834
|
-9.73%
|
✓
|
$230.4K |
| Mar 27, 2015 |
Mar 30, 2015 |
BIOGEN INC.
|
Grp SVP, Chief Medical Officer |
Sell |
37.5
|
-430
|
-4.78%
|
✓
|
$185K |
| Mar 1, 2015 |
Mar 3, 2015 |
BIOGEN INC.
|
Grp SVP, Chief Medical Officer |
Sell |
5.0
|
-6,000
|
-39.99%
|
✓
|
$2.5M |
| Feb 17, 2015 |
Feb 18, 2015 |
BIOGEN INC.
|
Grp SVP, Chief Medical Officer |
Sell |
41.3
|
-418
|
-2.71%
|
✓
|
$162.6K |
| Feb 12, 2015 |
Feb 17, 2015 |
BIOGEN INC.
|
Grp SVP, Chief Medical Officer |
Sell |
20.0
|
-757
|
-2.43%
|
✗
|
$296.8K |
| Feb 10, 2015 |
Feb 11, 2015 |
BIOGEN INC.
|
Grp SVP, Chief Medical Officer |
Sell |
30.0
|
-1,143
|
-7.27%
|
✓
|
$455K |
| Feb 8, 2015 |
Feb 10, 2015 |
BIOGEN INC.
|
Grp SVP, Chief Medical Officer |
Sell |
35.0
|
-1,958
|
-4.11%
|
✓
|
$780.2K |
| Dec 3, 2014 |
Dec 5, 2014 |
BIOGEN INC.
|
Grp SVP, Chief Medical Officer |
Sell |
30.0
|
-833
|
-5.41%
|
✓
|
$288.7K |
| Mar 4, 2014 |
Mar 5, 2014 |
BIOGEN INC.
|
Grp SVP, Chief Medical Officer |
Sell |
15.0
|
-3,171
|
-17.07%
|
✓
|
$1.1M |
| Mar 3, 2014 |
Mar 4, 2014 |
BIOGEN INC.
|
Grp SVP, Chief Medical Officer |
Sell |
20.0
|
-2,829
|
-13.22%
|
✗
|
$963.8K |
| Feb 26, 2014 |
Feb 27, 2014 |
BIOGEN INC.
|
Grp SVP, Chief Medical Officer |
Sell |
35.0
|
-1,048
|
-4.67%
|
✓
|
$358.6K |
| Feb 23, 2014 |
Feb 25, 2014 |
BIOGEN INC.
|
Grp SVP, Chief Medical Officer |
Sell |
20.0
|
-940
|
-4.02%
|
✗
|
$326.3K |
| Feb 12, 2014 |
Feb 14, 2014 |
BIOGEN INC.
|
Grp SVP, Chief Medical Officer |
Sell |
97.5
|
+6,948
|
48.05%
|
✓
|
$253K |
| Feb 11, 2014 |
Feb 12, 2014 |
BIOGEN INC.
|
Grp SVP, Chief Medical Officer |
Sell |
22.5
|
-2,085
|
-13.24%
|
✓
|
$655.3K |
| Feb 8, 2014 |
Feb 11, 2014 |
BIOGEN INC.
|
Grp SVP, Chief Medical Officer |
Sell |
20.0
|
-1,016
|
-3.25%
|
✗
|
$320.6K |